Sees Q4 adjusted EBITDA $1M-$2M.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NVRO:
- Nevro Reports Third Quarter 2023 Financial Results, Provides Fourth Quarter Guidance and Updates Full-Year 2023 Guidance
- Nevro price target lowered to $17 from $28 at BofA
- Nevro price target lowered to $20 from $30 at Mizuho
- Nevro price target lowered to $18.50 from $25 at Truist
- Nevro announces publication of data from study of 10 kHz Therapy